AgaMatrix Gets $1.3M Fees From Dexcom's Failed IP Suit
A California federal judge has ruled that diabetes glucose monitoring company Dexcom Inc. must pay rival AgaMatrix Inc. more than $1.3 million in fees after proceeding with patent infringement litigation that...To view the full article, register now.
Already a subscriber? Click here to view full article